Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC

Clinical trial NCT01761240 · COMPLETED

Trial details

NCT number: NCT01761240
Sponsor: Morphotek
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Pancreatic Cancer Colorectal Cancer Carcinoma, Non-Small-Cell Lung Adenocarcinoma

Start date: 2013-06-19
Primary completion: 2016-02-09
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.